Types of Neuroglia (Glial Cells) | CNS & PNS Support Cells Explained

The blood-brain barrier employs multiple molecular mechanisms for selective permeability: (1) Tight junctions block paracellular passage; (2) Absence of fenestrations prevents window-mediated entry; (3) Minimal vesicular transport restricts transcellular movement; (4) P-glycoprotein efflux pumps actively expel substances back into blood. Astrocytes regulate barrier integrity through foot processes that release soluble factors signaling endothelial cells to synthesize more tight junction proteins. In cancerous tissues lacking astrocytes, capillaries develop abnormal permeability. These integrated mechanisms create a sophisticated defense system protecting neurons from harmful substances while permitting essential nutrient entry.

The blood-brain barrier is formed by endothelium cells of brain capillaries along with tight junctions between these cells. Astrocyte foot processes regulate the permeability of the blood-brain barrier but do not form the barrier itself. The most common pathway for substance penetration through the blood-brain barrier is simple diffusion (transcellular transport by lipophilic substances). Bacteria and viruses can penetrate by disrupting paracellular transport or through transcellular processes.

The blood-brain barrier (BBB) is a selective barrier formed by tight junctions between endothelial cells, astrocyte foot processes, and pericytes. It allows essential nutrients (glucose, amino acids) to pass while blocking harmful substances. Lipophilic drugs cross the BBB more easily than hydrophilic drugs. Many chemotherapy drugs cannot cross the BBB, making brain metastases resistant to treatment.

Astrocytes perform multiple functions: structural support for neurons, nutrient transport from capillaries to neurons, regulation of interstitial fluid composition, excess potassium and neurotransmitter uptake, formation of the blood-brain barrier, formation of glial limiting membranes around brain surfaces, and phagocytic activity during injury response. The blood-brain barrier consists of capillary endothelium with tight junctions, basement membrane, and astrocyte foot processes with tight junctions. Permeable substances include hydrophobic hormones (steroids, thyroid hormones), glucose, amino acids, and nucleic acid bases. Impermeable substances include large proteins, bacteria, and viruses.

Astrocyte processes coat blood vessels and form tight junctions that selectively control molecular influx into the brain based on size and polarity. This creates significant challenges for drug delivery—drugs effective in laboratory settings may fail to cross the blood-brain barrier when administered systemically. Blood-brain barrier leaks occur when astrocytic feet dysfunction or deform, demonstrating the critical relationship between astrocyte morphology and barrier integrity. If astrocytes change shape, their ability to maintain protective barriers is compromised, potentially allowing harmful substances to enter the brain parenchyma and disrupt neural function.

The tripartite synapse model includes presynaptic neuron, postsynaptic neuron, and astrocyte (glial cell). Astrocytes clear synaptic glutamate via EAAT1/2 transporters, convert it to glutamine using glutamine synthetase, and release it back to neurons for reconversion to glutamate. Astrocytes also supply neurons with lactate for energy. This bidirectional metabolic coupling between neurons and astrocytes maintains synaptic function and prevents excitotoxicity by efficiently clearing excess glutamate from the synaptic cleft.

The tripartite synapse concept describes the synapse as involving three components: presynaptic neuron, postsynaptic neuron, and glial cells (astrocytes). Astrocytes clear neurotransmitters, provide metabolic support, and modulate synaptic transmission. Some glial cells can also release neurotransmitters. Signaling pathways include autocrine (cell signals itself), paracrine (nearby cells), endocrine (distant cells through hormones), and direct contact (gap junctions).

The tripartite synapse model reveals that neural communication involves not just neurons but also astrocytes, which regulate glutamate levels through the glutamate-glutamine cycle by providing glutamine to neurons, clearing excess glutamate from the synaptic cleft to prevent excitotoxicity, and releasing gliotransmitters that modulate synaptic function; dysfunction in this tripartite system contributes to neurodegenerative disorders.

Astrocytes perform multiple functions: structural support through GFAP filaments, formation of glia limitans covering the brain surface, perivascular processes forming the blood-brain barrier interface, and perisynaptic processes interacting with synapses. The tripartite synapse concept recognizes that chemical synapses consist of presynaptic neuron, postsynaptic neuron, and astrocyte. Astrocytes release gliotransmitters that modulate synaptic transmission. They clear neurotransmitters, regulate blood flow, and participate in synaptic plasticity. In white matter, astrocytes are particularly important at nodes of Ranvier. Their territorial organization and gap junction coupling create a functional syncytium.

Gliosis is a non-specific reactive change of glial cells in response to CNS damage from trauma, stroke, or injury. It involves proliferation (cell multiplication) and hypertrophy (increased cell size) of astrocytes, microglia, and oligodendrocytes. Following injury, dead cells undergo apoptosis and dissolve, creating empty spaces that surrounding astrocytes fill by proliferating and changing morphology. This forms a glial scar composed primarily of astrocytes that modifies the extracellular matrix and secretes inhibitory molecules preventing neuronal growth and regeneration. This natural inhibitory mechanism poses challenges for neural repair strategies, including stem cell implantation approaches aimed at replacing lost neurons.

When there is CNS injury and neuronal breakdown, astrocytes respond by migrating to fill the space created by cellular destruction. This process involves two key responses: hypertrophy (increase in size) and proliferation (increase in number). Astrocytes release interleukin-1 and prostaglandins as part of the inflammatory response. Microglia also enter the area to regulate inflammation. The combination of these processes leads to the formation of an astrocytic scar, which is considered a hallmark of CNS injury and occurs in all neurodegenerative diseases.

Glialosis is the body's response to injury in the central nervous system. When injury occurs, astrocytes become activated and multiply, developing extensive processes. Microglia also accumulate to consume dead cells. This results in scar tissue formation composed of astrocytes and microglia. Unlike peripheral tissue healing which uses fibroblasts and collagen, CNS scar tissue interferes with normal neural function and can impede nerve regeneration. This scar tissue acts as a barrier to prevent damage spread but creates functional impairment.

Apoptosis is a programmed, controlled cell death process that regulates normal cell growth and development, involving chromatin condensation, DNA fragmentation, and membrane changes. Necrosis is uncontrolled cell death from direct trauma. Three glial cell types respond to CNS injury: astrocytes express fibrillary proteins and form the glial scar; oligodendrocytes express inhibitory proteins (Nogo, MAG, OMIP) that prevent axon growth; microglia contribute to inflammation. These reactions create a hostile environment for regeneration, unlike peripheral nerve injury where Schwann cells promote regeneration.